Tenders of Aok Plus Die Gesundheitskasse F R Sachsen Und Th Ringen

AOK PLUS Die Gesundheitskasse F R Sachsen Und Th Ringen Tender

Germany
Germany – Pharmaceutical Products – Abschluss Nicht Exkl. Arzneimittel-rabattvereinb. Nach § 130a Abs. 8 Sgb V Im Wege Eines Open-house-modells Zum Wirkstoff Fingolimod (atc-code Nach Who: L04ae01)
Closing Date30 Sep 2026
Tender AmountRefer Documents 

AOK PLUS Die Gesundheitskasse F R Sachsen Und Th Ringen Tender

Germany
Conclusion not exclusive of drug discount agreement according to Section 130a Paragraph 8 SGB V by means of an open-house model for the active ingredient epinephrine (ATC code according to WHO: C01CA24) in the form of a pre-filled syringe/pen
Closing Date30 Sep 2025
Tender AmountRefer Documents 

AOK PLUS Die Gesundheitskasse F R Sachsen Und Th Ringen Tender

Corrigendum : Closing Date Modified
Germany
Conclusion of non-exclusive drug discount agreement pursuant to Section 130a, paragraph 8 of the Social Code Book V by means of an open-house model for the active ingredient miglustat (ATC code according to WHO: A16AX06)
Closing Date31 May 2027
Tender AmountRefer Documents 

AOK PLUS Die Gesundheitskasse F R Sachsen Und Th Ringen Tender

Germany
Conclusion of non-exclusive drug discount agreement pursuant to Section 130a, Paragraph 8 of the Social Code Book V by means of an open-house model for the active ingredient febuxostat (ATC code according to WHO: M04AA03)
Closing Date30 Sep 2026
Tender AmountRefer Documents 

AOK PLUS Die Gesundheitskasse F R Sachsen Und Th Ringen Tender

Healthcare and Medicine
Germany
Conclusion of non-exclusive drug discount agreement pursuant to Section 130a, paragraph 8 of the Social Code Book V by means of an open-house model for the active ingredient latanoprost/timolol (official ATC code: S01ED61)
Closing Date30 Sep 2026
Tender AmountRefer Documents 

AOK PLUS Die Gesundheitskasse F R Sachsen Und Th Ringen Tender

Healthcare and Medicine
Germany
Conclusion of non-exclusive drug discount agreement pursuant to Section 130a, paragraph 8 of the Social Security Code V by means of an open-house model for the active ingredient Telmisartan (ATC code according to WHO: C09CA07)
Closing Date30 Sep 2026
Tender AmountRefer Documents 

AOK PLUS Die Gesundheitskasse F R Sachsen Und Th Ringen Tender

Civil And Construction...+1Civil Works Others
Germany
Conclusion of non-exclusive drug discount agreement pursuant to Section 130a, paragraph 8 of the Social Code Book V by means of an open-house model for the active ingredient tolvaptan (ATC code: C03xa01)
Closing Date31 Aug 2026
Tender AmountRefer Documents 

AOK PLUS Die Gesundheitskasse F R Sachsen Und Th Ringen Tender

Civil And Construction...+2Others, Civil Works Others
Germany
Conclusion of non-exclusive drug discount agreement pursuant to Section 130a, Paragraph 8 of the Social Security Code V by means of an open-house model for the active ingredient lisdexamfetamine (ATC code according to WHO: N06BA12)
Closing Date31 Aug 2025
Tender AmountRefer Documents 

AOK PLUS Die Gesundheitskasse F R Sachsen Und Th Ringen Tender

Civil And Construction...+1Civil Works Others
Germany
Conclusion of non-exclusive drug discount agreement pursuant to Section 130a, paragraph 8 of the Social Code Book V by means of an open-house model for the active ingredient tolvaptan (ATC code: G04BX21)
Closing Date31 Aug 2026
Tender AmountRefer Documents 

AOK PLUS Die Gesundheitskasse F R Sachsen Und Th Ringen Tender

Healthcare and Medicine
Corrigendum : Closing Date Modified
Germany
Conclusion of non-exclusive drug discount agreement pursuant to Section 130a Paragraph 8 SGB V by means of an open-house model for the active ingredient peginterferon beta-1a (ATC code according to WHO: L03ab13)
Closing Date31 Jul 2026
Tender AmountRefer Documents 
121-130 of 199 active Tenders